Verition Fund Management LLC Immatics N.V. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Immatics N.V. stock. As of the latest transaction made, Verition Fund Management LLC holds 67,369 shares of IMTX stock, worth $291,034. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,369Holding current value
$291,034% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
82.1MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$45.8 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$40.5 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$31.4 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$28.3 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$27.1 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $329M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...